FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1161871000168109: Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) (chlorhexidine gluconate 500 microgram / 1 mL + lidocaine 20 mg / 1 mL) gel, 10 mL syringe (trade product unit of use)

Status: current, Defined. Date: 31-Jul 2018. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2561511000168114 Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) (chlorhexidine gluconate 500 microgram / 1 mL + lidocaine 20 mg / 1 mL) gel, 10 mL syringe (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
2561521000168119 Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 mL syringe en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 mL syringe Is a Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) true Inferred relationship Some
Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 mL syringe Is a lidocaine 2% + chlorhexidine gluconate 0.05% gel, syringe true Inferred relationship Some
Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 mL syringe Is a trade product unit of use true Inferred relationship Some
Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 mL syringe has manufactured dose form gel true Inferred relationship Some
Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 mL syringe has unit of use syringe true Inferred relationship Some 2071627435
Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 mL syringe has Australian BoSS chlorhexidine gluconate true Inferred relationship Some 965288595
Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 mL syringe has intended active ingredient chlorhexidine true Inferred relationship Some 965288595
Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 mL syringe has Australian BoSS lidocaine true Inferred relationship Some 2071627434
Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 mL syringe has intended active ingredient lidocaine true Inferred relationship Some 2071627434
Inbound Relationships Type Active Source Characteristic Refinability Group
Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 x 10 mL syringes has TPUU True Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 mL syringe Inferred relationship Some 1
Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 x 10 mL syringes has TPUU True Lignocaine 2% with Chlorhexidine 0.05% (Pfizer) gel, 10 mL syringe Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start